| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 11 |
| 1 | CARBOPLATIN | 7 |
| 2 | PACLITAXEL | 6 |
| 3 | IPILIMUMAB | 5 |
| 4 | OMEPRAZOLE | 3 |
| 5 | OMEPRAZOLE MAGNESIUM | 3 |
| 6 | AMLODIPINE | 2 |
| 7 | CYCLOPHOSPHAMIDE | 2 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 2 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NIVOLUMAB AND RELATLIMAB-RMBW | 1 | 0.0019 |
| 1 | FOSNETUPITANT AND PALONOSETRON | 2 | 0.0017 |
| 2 | NETUPITANT AND PALONOSETRON | 2 | 0.0017 |
| 3 | CEMIPLIMAB-RWLC | 1 | 0.0005 |
| 4 | PYRIDOXINE HYDROCHLORIDE | 1 | 0.0004 |
| 5 | ENFORTUMAB VEDOTIN | 1 | 0.0001 |
| 6 | IPILIMUMAB | 5 | 0.0001 |
| 7 | NIVOLUMAB | 11 | 0.0001 |
| 8 | PAROXETINE HYDROCHLORIDE HEMIHYDRATE | 2 | 0.0001 |
| 9 | PACLITAXEL | 6 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 33 | 0.0003 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 5 | 0.0001 |
| 4 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 5 | Bile Acid [EPC] | 1 | 0.0000 |
| 6 | Microtubule Inhibitor [EPC] | 6 | 0.0000 |
| 7 | Platinum-based Drug [EPC] | 9 | 0.0000 |
| 8 | Erythropoiesis-stimulating Agent [EPC] | 1 | 0.0000 |
| 9 | Serotonin-3 Receptor Antagonist [EPC] | 2 | 0.0000 |